BRCA2 and prostate cancer: BRCA1 and BRCA2 mutations increased the incidence of pancreatic cancer (RR 3–5) and uterine cancer (RR 1.5) but were not associated with brain cancer, colorectal cancer, prostate cancer, bladder and kidney cancer, cervical cancer or malignant melanoma.